# Evaluating the Implementation of a “COVID-19 Test” Chief Concern in the Emergency Department

**Authors:** Collin Michels, Daniel J. Hekman, Rebecca J. Schwei, Ryan E. Tsuchida, Joshua Gauger, Irene Hurst, Joshua Glazer, Jenna Brink, Ciara Barclay-Buchanan, Manish N. Shah, Azita G. Hamedani, Michael Pulia

PMC · DOI: 10.5811/westjem.34850 · 2025-05-02

## TL;DR

This study examines how a new 'COVID-19 Test' chief concern in emergency departments affected patient care and outcomes during the pandemic.

## Contribution

The study introduces and evaluates a new chief concern category for ED patients seeking only a COVID-19 test.

## Key findings

- 45% of patients assigned the 'COVID-19 Test' chief concern tested positive for SARS-CoV-2.
- 46.9% of these patients received additional ED interventions despite the low risk of admission or return visits.
- Minoritized and low-income patients were overrepresented in the 'COVID-19 Test' group, suggesting disparities in at-home testing access.

## Abstract

During the COVID-19 pandemic, rapid, at-home testing for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was inconsistently available. Consequently, for some patients, emergency departments (ED) became the preferred site to access COVID-19 testing. To improve operational efficiency, our ED implemented a “COVID-19 Test” chief concern (CC). Our primary objective in this analysis was to broadly assess the utilization of the new “COVID-19 Test” CC and associated clinical care.

We conducted a retrospective analysis of ED encounters from an academic ED and an affiliated, community-based ED of all patients after the establishment of a CC of “COVID-19 Test” from October 11, 2021–July 31, 2022. The data were extracted from the electronic health record. We calculated descriptive demographic statistics and ran a univariate and multivariate logistic regression with additional diagnostic or therapeutic interventions (binary) as the outcome variable to generate odds ratios (OR) and 95% confidence intervals (CI).

A total of 320 patients were assigned a “COVID-19 Test” CC by a triage nurse. This was 0.5% of all ED encounters in this time frame. Of those, 45% were found to be SARS-CoV-2 positive. Admission or repeat ED visit at 72 hours occurred in 5.3% of patients. Nearly half (46.9%) of patients assigned a “COVID-19 Test” CC underwent additional ED interventions. Patients on Medicaid and those who self-identified as Black or Hispanic/Latino were disproportionately represented in the “COVID-19 Test” CC group as compared to the overall ED population. In multivariate analysis, an Emergency Severity Index of 1, 2 or 3 was associated with significantly higher odds of receiving additional interventions compared to ESI of 4 or 5 (adjusted OR: 46.85; 95% CI 13.28–165.26; P <0.001).

Patients assigned a chief concern of “COVID-19 Test” had a high COVID-19 positivity rate, often underwent additional ED interventions, and were at low risk of return ED visits or admission. Minoritized and low-income patients were disproportionately represented in the “COVID-19 Test” CC group, highlighting potential disparities in access to at-home COVID-19 testing and implementation of this CC.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096), severe acute respiratory syndrome-coronavirus-2 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12208069